JENNIFER L GOOD
CIK 1229245 · President & CEO · last filed 2026-02-20
JENNIFER L GOOD is a President & CEO who has filed 43 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for TRVI, was dated Feb 20, 2026. Across all open-market trades the lifetime net is −$4.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.72M
4
43
-$4.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRVI | President & CEO | 218,576 | $14.21 | $3.11M | -$195.5K | 19 | 2026-02-20 |
| RYTM | Director | 7,000 | $88.38 | $618.7K | -$4.27M | 12 | 2025-06-26 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $0 | 2 | 2018-08-15 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | President & CEO | 18,034 | — | — | $16.1K | 10 | 2010-09-22 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-20 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2025-06-23 | RYTM | Exer (M) | +4,000 | $0 | EDGAR |
| 2025-06-03 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-03-25 | TRVI | Mixed | — | -$27.1K | EDGAR |
| 2025-03-12 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-02-20 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2024-09-19 | RYTM | Mixed | — | -$979.7K | EDGAR |
| 2024-09-11 | RYTM | Mixed | — | -$1.38M | EDGAR |
| 2024-09-09 | TRVI | Mixed | — | -$9.7K | EDGAR |